STOCKWATCH
·
Residential- Commercial Projects
Acquisitions24 Jul 2025, 07:27 pm

Elpro International Acquires 95,454 Equity Shares of Natco Pharma Ltd for INR 10.01 Crores

AI Summary

Elpro International Ltd has acquired 95,454 equity shares of Natco Pharma Limited, a global leader in niche pharmaceutical products. The acquisition was made for a consideration of INR 10.01 Crores. Natco Pharma, incorporated in 1981, has a consolidated turnover of INR 4,784.00 Crores in FY 2024-25. The acquisition is not a related party transaction and does not involve any governmental or regulatory approvals. The acquisition is expected to enhance Elpro International's pharmaceutical portfolio.

Key Highlights

  • Elpro International acquires 95,454 equity shares of Natco Pharma Ltd
  • Consideration for the acquisition is INR 10.01 Crores
  • Natco Pharma is a global leader in niche pharmaceutical products
  • Natco Pharma has a consolidated turnover of INR 4,784.00 Crores in FY 2024-25
  • The acquisition does not involve any related party transactions or regulatory approvals
ELPROINTL
Residential- Commercial Projects
ELPRO INTERNATIONAL LTD.

Price Impact